Although previous findings have shown that KMT2C is a promising target for the treatment of cervical and bladder cancers, the specific molecular mechanisms involved in the regulation of KMT2C in cervical and bladder cancers remain to be further investigated. Here, KMT2C is linked to urinary bladder cancer.